On November 11, 2021 Quanterix Corporation (NASDAQ: QTRX), a company digitizing biomarker analysis to advance the science of precision health, reported that members of its executive leadership team will participate in a virtual fireside chat discussion at the Canaccord Genuity Virtual MedTech, Diagnostics and Digital Health & Services Forum on Nov. 18 at 8:30 a.m., EST (Press release, Quanterix, NOV 11, 2021, View Source [SID1234595293]). The virtual fireside chat discussion will feature Chairman and Chief Executive Officer, Kevin Hrusovsky; President of Quanterix and Diagnostics, Masoud Toloue; Chief Financial Officer, Mike Doyle and Director of Investor Relations and Business Development, Stephen Hrusovsky.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Hrusovsky will also host virtual one-on-one meetings with institutional investors that day. A live webcast of the conversation will be available on the investor section of the Quanterix website at View Source Replays of the webcast will be available on the Quanterix website for 90 days following the conference.